Effects of the selective GPER-1 agonist G1 on bone growth

in Endocrine Connections
Correspondence: Maryam Iravani, Email: maryam.iravani@ki.se

Estrogens may affect bone growth locally or systemically via the known estrogen receptors ERα, ERβ and G protein-coupled estrogen receptor 1 (GPER-1). Mouse and human growth plate chondrocytes have been demonstrated to express GPER-1 and ablation of this receptor increased bone length in mice. Therefore, GPER-1 is an attractive target for therapeutic modulation of bone growth, which has never been explored. To investigate the effects of activated GPER-1 on the growth plate, we locally exposed mouse metatarsal bones to different concentrations of the selective GPER-1 agonist G1 for 14 days ex vivo. The results showed that none of the concentrations of G1 had any direct effect on metatarsal bone growth when compared to control. To evaluate if GPER-1 stimulation may systemically modulate bone growth, ovariectomized C57BL/6 mice were treated with G1 or, β-estradiol (E2). Similarly, G1 did not influence tibia and femur growth in treated mice. As expected, E2 treatment suppressed bone growth in vivo. We conclude that ligand stimulation of GPER-1 does not influence bone growth in mice.

If the inline PDF is not rendering correctly, you can download the PDF file here.

 

     European Society of Endocrinology

     Society for Endocrinology

Related Articles

Article Information

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 88 88 88
PDF Downloads 80 80 80

Altmetrics

PubMed

Google Scholar